PERKINS CAPITAL MANAGEMENT INC
Reported holdings as of Q2 2026, from 30 quarterly filings.
Holdings
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| NATERA INC | NTRA | $11.0M | 40,605 | -0.02pp | 30q | -8.3%-$1.0M | |
| ELI LILLY & CO | LLY | $10.4M | 8,680 | +0.22pp | 30q | -1.7%-$179.9K | |
| ADVANCED MICRO DEVICES INC | AMD | $8.1M | 13,904 | +3.12pp | 30q | -10.3%-$929.5K | |
| BUTTERFLY NETWORK INC | BFLY | $7.3M | 867,580 | +1.97pp | 6q | -6.8%-$533.4K | |
| AXOGEN INC | AXGN | $6.8M | 147,842 | -0.11pp | 30q | -12.4%-$970.0K | |
| INUVO INC | INUV | $6.5M | 515,011 | +3.75pp | 5q | -11.6%-$847.7K | |
| QUICKLOGIC CORP | QUIK | $5.1M | 257,621 | +1.17pp | 26q | -16.0%-$980.2K | |
| IDEXX LABS INC | IDXX | $5.1M | 9,700 | -1.27pp | 30q | HELD | |
| BACKBLAZE INC | BLZE | $4.9M | 308,725 | +2.59pp | 16q | -8.9%-$480.6K | |
| MICROSOFT CORP | MSFT | $4.2M | 11,173 | -0.83pp | 30q | -2.1%-$90.3K | |
| VERACYTE INC | VCYT | $3.5M | 59,958 | +0.37pp | 30q | -20.4%-$903.0K | |
| OOMA INC | OOMA | $3.4M | 176,970 | +0.09pp | 30q | -2.4%-$82.3K | |
| PERSONALIS INC | PSNL | $3.2M | 239,000 | +0.98pp | 9q | HELD | |
| CRYOPORT INC | CYRX | $3.1M | 199,897 | +0.78pp | 30q | -1.6%-$52.6K | |
| CIENA CORP | CIEN | $3.1M | 6,300 | -0.91pp | 30q | HELD | |
| LEMAITRE VASCULAR INC | LMAT | $2.4M | 25,345 | -0.81pp | 16q | -1.9%-$46.1K | |
| MAGNITE INC | MGNI | $1.9M | 98,625 | +0.08pp | 24q | -17.3%-$391.9K | |
| ABBOTT LABORATORIES | ABT | $1.8M | 20,257 | -0.61pp | 30q | -1.9%-$36.5K | |
| USIO INC | USIO | $1.7M | 700,371 | +0.56pp | 15q | HELD | |
| ONDAS INC | ONDS | $1.7M | 201,483 | -0.46pp | 5q | HELD | |
| NEOGENOMICS INC | NEO | $1.6M | 110,040 | +0.29pp | 30q | -16.9%-$325.5K | |
| PERION NETWORK LTD | PERI | $1.6M | 165,215 | -0.26pp | 22q | +5.3%+$81.1K | |
| NEOGEN CORP | NEOG | $1.6M | 177,500 | -0.35pp | 3q | HELD | |
| CREXENDO INC | CXDO | $1.6M | 212,825 | +0.07pp | 7q | +9.2%+$134.3K | |
| ALPHATEC HLDGS INC | ATEC | $1.5M | 175,197 | -0.61pp | 27q | +1.9%+$29.0K | |
| ABBVIE INC | ABBV | $1.3M | 5,307 | -0.08pp | 29q | -0.7%-$8.8K | |
| CREATIVE REALITIES INC | CREX | $1.2M | 300,050 | - | new | NEW | |
| LUCID DIAGNOSTICS INC | LUCD | $1.2M | 1,125,000 | -0.31pp | 4q | HELD | |
| CODEXIS INC | CDXS | $1.2M | 526,100 | +0.09pp | 12q | HELD | |
| ZETA GLOBAL HOLDINGS CORP | ZETA | $1.1M | 55,900 | -0.01pp | 4q | HELD | |
| TRISALUS LIFE SCIENCES INC | TLSI | $1.1M | 235,101 | -0.06pp | 2q | +2.2%+$22.8K | |
| TELA BIO INC | TELA | $1.0M | 1,375,042 | -0.05pp | 16q | -3.1%-$32.5K | |
| BIODESIX INC | BDSX | $1.0M | 44,618 | +0.15pp | 4q | HELD | |
| SAFE PRO GROUP INC | SPAI | $998.1K | 230,500 | -0.08pp | 2q | HELD | |
| MERCK & CO INC | MRK | $963.8K | 7,500 | -0.15pp | 30q | -3.2%-$32.1K | |
| GILEAD SCIENCES INC | GILD | $911.7K | 7,216 | -0.26pp | 25q | HELD | |
| VIATRIS INC | VTRS | $854.9K | 53,837 | -0.05pp | 7q | -1.9%-$16.8K | |
| PFIZER INC | PFE | $812.9K | 33,759 | -0.33pp | 30q | -6.0%-$51.8K | |
| BLACKSKY TECHNOLOGY INC | BKSY | $802.7K | 28,750 | -0.07pp | 8q | HELD | |
| APPLE INC | AAPL | $766.8K | 2,650 | -0.05pp | 30q | HELD | |
| PROFOUND MED CORP | PROF | $760.0K | 114,280 | -0.12pp | 3q | HELD | |
| US BANCORP | USB | $745.9K | 12,350 | -0.05pp | 30q | -1.6%-$12.1K | |
| NEUROONE MED TECHNOLOGIES CO | NMTC | $743.8K | 244,656 | - | new | NEW | |
| VIDA GLOBAL INC | VIDA | $700.0K | 250,000 | - | new | NEW | |
| TARGET CORP | TGT | $620.4K | 4,750 | -0.09pp | 30q | -3.1%-$19.6K | |
| OWLET INC | OWLT | $611.3K | 106,495 | -0.05pp | 3q | HELD | |
| ELAUWIT CONNECTION INC | ELWT | $597.9K | 55,500 | +0.14pp | 3q | HELD | |
| MDXHEALTH SA | MDXH | $579.7K | 1,411,891 | -2.75pp | 11q | -4.4%-$26.5K | |
| SEAGATE TECHNOLOGY HLDNGS PL | STX | $506.6K | 525 | +0.18pp | 2q | -4.5%-$24.1K | |
| ATRICURE INC | ATRC | $489.6K | 17,500 | -0.33pp | 30q | -33.0%-$240.6K | |
| CONOCOPHILLIPS | COP | $483.4K | 4,650 | -0.24pp | 10q | -4.1%-$20.8K | |
| NXP SEMICONDUCTORS N V | NXPI | $477.8K | 1,700 | +0.03pp | 27q | -5.6%-$28.1K | |
| LIFEVANTAGE CORP | LFVN | $470.9K | 75,458 | +0.05pp | 30q | HELD | |
| CELCUITY INC | CELC | $470.8K | 4,500 | -0.22pp | 6q | -16.7%-$94.2K | |
| GENERAL MILLS INC | GIS | $434.4K | 8,375 | +0.02pp | 30q | -5.6%-$25.9K | |
| SKYWATER TECHNOLOGY INC | SKYT | $414.4K | 11,900 | -0.37pp | 15q | -54.9%-$504.9K | |
| BRISTOL-MYERS SQUIBB CO | BMY | $413.7K | 7,180 | -0.11pp | 30q | -3.4%-$14.4K | |
| DONALDSON INC | DCI | $412.9K | 4,600 | -0.06pp | 30q | HELD | |
| QT IMAGING HLDGS INC | QTI | $407.0K | 100,000 | - | new | NEW | |
| VERIZON COMMUNICATIONS INC | VZ | $385.6K | 9,108 | -0.14pp | 30q | HELD | |
| CASTLE BIOSCIENCES INC | CSTL | $384.9K | 16,140 | -0.07pp | 27q | +4.7%+$17.3K | |
| ELUTIA INC | ELUT | $379.9K | 694,094 | -0.46pp | 23q | -8.3%-$34.4K | |
| FASTENAL CO | FAST | $348.2K | 7,250 | -0.05pp | 30q | HELD | |
| AT&T INC | T | $331.0K | 15,992 | -0.19pp | 30q | HELD | |
| BP PLC | BP | $319.6K | 8,650 | -0.16pp | 20q | -6.0%-$20.3K | |
| JOHNSON & JOHNSON | JNJ | $304.8K | 1,200 | -0.05pp | 23q | HELD | |
| BEELINE HOLDINGS INC | BLNE | $290.4K | 238,000 | -0.32pp | 3q | -2.9%-$8.5K | |
| MODERNA INC | MRNA | $280.1K | 4,000 | +0.02pp | 2q | HELD | |
| EXAGEN INC | XGN | $264.1K | 56,796 | flat | 27q | -20.9%-$69.7K | |
| APYX MEDICAL CORPORATION | APYX | $188.6K | 42,000 | flat | 18q | HELD | |
| AIRGAIN INC | AIRG | $138.6K | 22,000 | -0.01pp | 30q | HELD | |
| PUMA BIOTECHNOLOGY INC | PBYI | $108.7K | 13,400 | +0.01pp | 4q | +7.2%+$7.3K | |
| OPTIMIZERX CORP | OPRX | $84.7K | 14,808 | -0.03pp | 30q | -6.9%-$6.3K | |
| IRIDEX CORP | IRIX | $81.1K | 70,800 | +0.01pp | 30q | +28.0%+$17.7K | |
| PERSPECTIVE THERAPEUTICS INC | CATX | $62.1K | 18,200 | - | new | NEW | |
| SOPHIA GENETICS SA | SOPH | $60.6K | 10,500 | flat | 3q | HELD | |
| PULMONX CORP | LUNG | $51.4K | 39,500 | -0.01pp | 5q | -3.7%-$1.9K | |
| DYADIC INTL INC DEL | DYAI | $43.1K | 48,050 | flat | 28q | HELD | |
| ACCURAY INC DEL | ARAY | $5.2K | 20,000 | -0.02pp | 17q | -61.9%-$8.4K |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Biotech & Pharma | $29.0M | 21.8% |
| Medical Devices | $25.1M | 18.9% |
| Healthcare Services | $20.5M | 15.4% |
| Semiconductors & Electronics | $19.8M | 14.9% |
| Software & IT Services | $18.3M | 13.8% |
| Business Services | $8.2M | 6.2% |
| Telecom & Media | $2.9M | 2.2% |
| Banks & Lending | $2.8M | 2.1% |
| Other sectors | $5.7M | 4.3% |
| Not classified | $700.0K | 0.5% |
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $133.0M | 79 | 5 | 7 | 39 | 12 | 52.2% | 24 |
| Q1 2026 | $106.7M | 86 | 4 | 11 | 43 | 9 | 45.8% | 23 |
| Q4 2025 | $125.9M | 91 | 9 | 14 | 43 | 1 | 46.7% | 35 |
| Q3 2025 | $113.5M | 83 | 6 | 13 | 41 | 6 | 43.5% | 31 |
| Q2 2025 | $99.5M | 83 | 6 | 10 | 40 | 5 | 44.6% | 38 |
| Q1 2025 | $94.8M | 82 | 5 | 8 | 33 | 4 | 44.5% | 37 |
| Q4 2024 | $112.7M | 81 | 6 | 17 | 45 | 9 | 41.3% | 42 |
| Q3 2024 | $106.6M | 84 | 4 | 10 | 47 | 8 | 45.1% | 31 |
| Q2 2024 | $106.1K | 88 | 3 | 9 | 46 | 5 | 44.3% | 40 |
| Q1 2024 | $119.9K | 90 | 4 | 12 | 21 | 6 | 41.0% | 39 |
| Q4 2023 | $117.1K | 92 | 4 | 27 | 30 | 10 | 40.4% | 22 |
| Q3 2023 | $100.9K | 98 | 6 | 5 | 31 | 5 | 39.1% | 33 |
| Q2 2023 | $114.8K | 97 | 4 | 12 | 46 | 4 | 36.9% | 21 |
| Q1 2023 | $106.1K | 97 | 5 | 21 | 36 | 8 | 34.4% | 39 |
| Q4 2022 | $94.7K | 100 | 6 | 17 | 28 | 10 | 35.6% | 26 |
| Q3 2022 | $89.4M | 104 | 7 | 11 | 62 | 8 | 34.8% | 24 |
| Q2 2022 | $96.6M | 105 | 7 | 33 | 19 | 12 | 32.6% | 29 |
| Q1 2022 | $122.0M | 110 | 5 | 25 | 20 | 4 | 29.7% | 20 |
| Q4 2021 | $148.1M | 109 | 14 | 22 | 45 | 11 | 33.0% | 41 |
| Q3 2021 | $161.5M | 106 | 5 | 9 | 20 | 5 | 35.8% | 25 |
| Q2 2021 | $176.2M | 106 | 9 | 23 | 29 | 8 | 35.0% | 28 |
| Q1 2021 | $172.9M | 105 | 14 | 30 | 30 | 9 | 35.7% | 28 |
| Q4 2020 | $152.9M | 100 | 16 | 26 | 37 | 9 | 41.1% | 40 |
| Q3 2020 | $108.9M | 93 | 8 | 18 | 45 | 22 | 40.5% | 28 |
| Q1 2020 | $82.8M | 107 | 13 | 21 | 46 | 18 | 36.3% | 29 |
| Q4 2019 | $111.5M | 112 | 13 | 12 | 69 | 13 | 35.0% | 34 |
| Q3 2019 | $116.1M | 112 | 9 | 15 | 62 | 7 | 31.9% | 23 |
| Q2 2019 | $142.8M | 110 | 4 | 23 | 56 | 18 | 33.6% | 40 |
| Q1 2019 | $151.9M | 124 | 17 | 30 | 60 | 19 | 33.5% | 22 |
| Q4 2018 | $129.0M | 126 | 0 | 0 | 0 | 0 | 35.0% | 42 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.